We have discussed this
before, several times. The piece you are linking to is PR by the company, not a third party report of scientific research. That Japan has approved it signifies a safety rather than efficacy record.
If you compare the writing and measures of success used with "real" pharmaceutical companies (whatever you may think of them, they have brought numerous effective treatments into the world), you see that they are quoting patients' e-mails -- patients who knew they were getting and fought to get this particular drug. There are no objective measures here at all apart from previously-reported trials with very weak results, so weak that investigators publicly rebuked the company for mischaracterizing progress and obscuring raw data. There is no evidence this drug will ever get to market in the US, and that is not, as the company would have it, some vast conspiracy. Taking it is one thing. Going abroad to get it is another.
Jen, we have posted strategies that seem to work for more people, more reliably and less expensively. I will stand by my advice to max out those out.
Best,
Laurie